NLRP1 and Salla disease: Treatment with modafinil reduced inflammasome activity and neuronal pyroptosis via the NLRP3/NLRP1/NLRC4-caspase-1-IL-1β pathway. Targeting the regulation of impaired neuronal pyroptosis and neuroinflammation may be a promising therapeutic strategy for treatment of SD.